cURL Error: Failed to connect to 217.15.170.3 port 80 after 1063 ms: Couldn't connect to server Monitoring of ABT situation on February 07, 2025
Stocks Prognosis
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site

Abbott Laboratories NYSE:ABT Continues to Impress with Q4 Sales

Published on February 7, 2025
Abbott Laboratories NYSE:ABT has reported its Q4 sales, which are in line with market estimates. The company, known for its innovative healthcare solutions, has consistently showcased its strong performance and growth potential. With its commitment to research and development, Abbott Laboratories has earned its spot on investors' watchlists. In fact, financial experts at Argus have upgraded the company's rating to a strong-buy. With its promising results and strong market presence, Abbott Laboratories ABT proves to be one of the best cancer stocks to invest in, as recommended by hedge funds. To make informed decisions about the movement of ABT stocks, it is advised to consult professionals at Stocks Prognosis.
Go to ABT Page

Investor opinions & comments

To leave a comment, you need to Login or Register.

There are no comments yet. Be the first to leave one!

Other Data for ABT

Investors Heavily Search Abbott Laboratories NYSE:ABT: Here is What You Need

September 18, 2025

Abbott Laboratories NYSE:ABT Earnings Are Of Questionable Quality

August 9, 2025

Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know

June 5, 2025

Abbott Laboratories Continues to Drive Growth in the Healthcare Sector

March 18, 2025

Abbott Laboratories: A Leader in Healthcare Innovation

March 17, 2025

Abbott Laboratories: Breaking New Ground in Healthcare Innovation

March 16, 2025

Related Data

Is There More Upside For ABT Stock After A 10% Jump In A Week?

February 3, 2025

Abbott Laboratories Reports Q4 Sales in Line with Estimates

February 4, 2025

Investors Rejoice: Abbott Laboratories NYSE:ABT Sees a Respectable 43% Return Over Past Five Years

December 27, 2024

Investors Heavily Search Abbott Laboratories NYSE:ABT: Here is What You Need

September 18, 2025

Abbott Laboratories NYSE:ABT Reports Impressive Dividend Growth and Shareholder Returns

November 17, 2024